InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Grip it and Sip It post# 14686

Wednesday, 05/17/2017 6:54:35 AM

Wednesday, May 17, 2017 6:54:35 AM

Post# of 232952
Good that trial at least started but it is not a mover for SP due to its long duration

- Enrolling 60 patients may be more difficult than 30 patients for adjunct as it is not common condition
- as per original protocol - enrollment period was 1 year - so if everything goes right - Jun 2018
- primary out come 100 days after treatment
- secondary outcome- follow up 100 and 365 days - so 1 year after last patient dosing

Overall this product will be relevant in 2019 - if company can survive till that time

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News